
Sign up to save your podcasts
Or


New medicines with sales in the billions of dollars each year are what every pharmaceutical company dreams of, but how do you create one and can they really justify their often high price tags?
Evan Davis and guests discuss the changing origins of so-called 'blockbusters' and their importance to the global drug industry, including recent examples like the obesity and diabetes treatments Wegovy and Ozempic, which have made Novo Nordisk one of the richest companies in Europe.
Plus, as outright cures for some diseases begin to emerge, how can the pharmaceutical industry and healthcare systems agree on what is a reasonable price to pay for them?
Evan is joined by:
Sir Patrick Vallance, former president of research and development at GSK, chief scientific advisor to the UK government, now chair of the Natural History Museum;
PRODUCTION TEAM:
Producer: Simon Tulett
(Picture: Rolls of dollar bills next to a bottle of pills. Credit: Getty Images)
By BBC Radio 44.7
3232 ratings
New medicines with sales in the billions of dollars each year are what every pharmaceutical company dreams of, but how do you create one and can they really justify their often high price tags?
Evan Davis and guests discuss the changing origins of so-called 'blockbusters' and their importance to the global drug industry, including recent examples like the obesity and diabetes treatments Wegovy and Ozempic, which have made Novo Nordisk one of the richest companies in Europe.
Plus, as outright cures for some diseases begin to emerge, how can the pharmaceutical industry and healthcare systems agree on what is a reasonable price to pay for them?
Evan is joined by:
Sir Patrick Vallance, former president of research and development at GSK, chief scientific advisor to the UK government, now chair of the Natural History Museum;
PRODUCTION TEAM:
Producer: Simon Tulett
(Picture: Rolls of dollar bills next to a bottle of pills. Credit: Getty Images)

7,913 Listeners

376 Listeners

863 Listeners

1,067 Listeners

50 Listeners

40 Listeners

5,576 Listeners

1,808 Listeners

1,729 Listeners

1,018 Listeners

2,113 Listeners

1,952 Listeners

790 Listeners

73 Listeners

227 Listeners

75 Listeners

108 Listeners

745 Listeners

143 Listeners

3,245 Listeners

1,600 Listeners

3,858 Listeners

851 Listeners

195 Listeners

48 Listeners